Founded Date:
2005
Employee Number:
11-50
Technology:
Immunotherapy
Investor Type:
N/A
Headquarters:
New York, United States
Total Funding:
N/A
Estimated Revenue:
$1M to $10M
Investment Stage:
N/A
Industry:
PharmTech